Location: Arthropod-Borne Animal Diseases Research
2013 Annual Report
ABADRU research staff members were provided new or refresher training as needed by Kansas State University in Institutional Animal Care and Use, Institutional Biosafety Committee, and Export Control policies and procedures. All modules were completed.
Additional BRI activities and accomplishments included physical walk-thru of facilities and review of procedures associated with multiple research program planning meetings for projected laboratory and animal space use and ongoing research project support. This included Rift Valley fever virus (RVFV)-MP12 research with lambs, calves, and mice as well as exotic bluetongue virus (BTV) lab work.
BRI Biosafety staff and Laboratory Coordinators worked with ABADRU research staff members to develop biosafety manuals and standard operating procedures specific to the current and future research activities.
The arthropod containment space for exotic BTV transmission studies was made ready in November of 2011 and inspected for approvals by Select Agent regulatory officials (see below) to enable ABADRU to continue Culicoides vector transmission work in the BRI. Two ABADRU scientists were given Adjunct Faculty status in the Department of Diagnostic Medicine and Pathobiology (Ruder) or the Department of Entomology (Nayduch) at Kansas State University.
ABADRU representation to K-State Institutional Biosafety Committee and Institutional Animal Care and Use Committees continues. Several IBC and IACUC approvals have been processed and approved through the full committee, including: MP12 mouse antibody production, wild type Rift valley fever lab work, exotic BTV lab and insect work, and Schmallenberg virus lab work.
Regulatory compliance reviews of proposed ABADRU research projects by the K-State Institutional Biosafety Committee and Institutional Animal Care and Use Committee have been conducted. Approvals have been completed prior to initiation of all research activities.
USDA, ABADRU research project occupy large animal holding spaces, small animal vivarium spaces and biocontainment laboratories of the BRI.
Permits, Select Agent approval, and research status:
BRI Biosafety staff worked with ABADRU research staff to submit applications to the Centers for Disease Control and USDA, APHIS for storage and use of select agent pathogens in research. The application process included current specific project, facility, and safety and security program descriptions, as well as personnel security risk assessments. All 9 ABADRU staff members have satisfied training and registration requirements for individual Select Agent Security Risk Assessment (SRA) have received SRA approval. BRI staff facilitated all required associated site inspections and follow up (CDC, USDA and DHS).
Laboratory (in vitro) work with Exotic Bluetongue Virus in designated BSL-3 space is now ongoing and is supported with BRI use fees. Additionally, as of spring 2013, wild type Rift Valley fever virus and Schmallenberg virus lab work is being conducted.
Rift Valley Fever Virus lab research is ongoing and is supported by BRI lab use fees.
Following submission of an application for Rift Valley Fever Virus (animal and laboratory work) in FY11, a Select Agent inspection was conducted in January 2012 and approval was received for lab and small animal work in December 2012. Approval for BSL-3Ag and ACL-3 RVFV work is still pending.
Following submission of an application for Exotic Bluetongue virus insect transmission studies in FY11, a Select Agent inspection was conducted in January 2012. Exotic BTV was removed from the select agent list effective 12/04/2012, before this insect transmission work was approved. The required APHIS permit was received in early 2013.